Author:
Lazzeri Massimo,Abrate Alberto,Lughezzani Giovanni,Gadda Giulio Maria,Freschi Massimo,Mistretta Francesco,Lista Giuliana,Fossati Nicola,Larcher Alessandro,Kinzikeeva Ella,Buffi Nicolòmaria,Dell'Acqua Vincenzo,Bini Vittorio,Montorsi Francesco,Guazzoni Giorgio
Reference26 articles.
1. Variability of repeated serum prostate-specific antigen (PSA) measurements within less than 90 days in a well-defined patient population;Roehrborn;Urology,1996
2. Variation in prostate specific antigen results from 2 different assay platforms: clinical impact on 2304 patients undergoing prostate cancer screening;Link;J Urol,2004
3. Serum isoform [-2]proPSA derivatives significantly improve prediction of prostate cancer at initial biopsy in a total PSA range of 2-10 ng/ml: a multicentric European study;Lazzeri;Eur Urol,2013
4. Development and internal validation of a Prostate Health Index based nomogram for predicting prostate cancer at extended biopsy;Lughezzani;J Urol,2012
5. Lazzeri M, Lughezzani G, Larcher A, et al: Reply to Sergey Tadtayev, Thomas A. McNicholas, and Gregory B. Boustead's Letter to the Editor re: Giorgio Guazzoni, Massimo Lazzeri, Luciano Nava, et al. Preoperative Prostate-Specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer. Eur Urol 2012; 61: 455-466. Eur Urol 2012; 62: e16-e17.
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献